On the other hand, this tumor is characterized by an unusual inflamed immune cell microenvironment, with lymphoid follicle formation, a high proportion of CD8+ cytotoxic tumor-infiltrating lymphocytes, and plasma cells, which suggests that the composition of the tumor immune microenvironment may influence response to immunotherapy (20). This evidence concerns the gene CD8A and neoplasm.